{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:05:45Z","timestamp":1786997145223,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.steroids.2006.05.017","type":"journal-article","created":{"date-parts":[[2006,7,13]],"date-time":"2006-07-13T08:18:54Z","timestamp":1152778734000},"page":"865-874","source":"Crossref","is-referenced-by-count":7,"title":["Nuclear type II [3H]estradiol binding site ligands: inhibition of ER-positive and ER-negative cell proliferation and c-Myc and cyclin D1 gene expression"],"prefix":"10.1016","volume":"71","author":[{"given":"Barry M.","family":"Markaverich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Shoulars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary-Ann","family":"Alejandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2006.05.017_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(78)91622-4","article-title":"Heterogeneity of estrogen receptors in the cytosol and nuclear fractions of the rat uterus","volume":"81","author":"Eriksson","year":"1978","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib2","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1210\/endo-105-6-1458","article-title":"Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response","volume":"105","author":"Markaverich","year":"1979","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib3","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1210\/endo-114-3-814","article-title":"The effect of low dose continuous exposure to estradiol on the estrogen receptor (type i) and nuclear type ii sites","volume":"114","author":"Markaverich","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-4731(81)90164-3","article-title":"Progesterone and dexamethasone antagonism of uterine growth: a role for a second nuclear estrogen binding site for estradiol in estrogen action","volume":"14","author":"Markaverich","year":"1981","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.steroids.2006.05.017_bib5","first-page":"163","article-title":"Estrogen receptors: selective ligands, partners, and distinctive pharmacology","volume":"55","author":"Katzenellenbogen","year":"2000","journal-title":"Recent Prog Horm Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsbmb.2004.12.047","article-title":"Nuclear type ii [3h]estradiol binding sites: a histone h3\u2013h4 complex","volume":"96","author":"Shoulars","year":"2005","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2006.05.017_bib7","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0006-291X(02)02042-9","article-title":"Identification of rat uterine nuclear type ii [3h]estradiol binding sites as histone h4","volume":"296","author":"Shoulars","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib8","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1016\/S0021-9258(18)68628-4","article-title":"Methyl p-hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear type ii binding sites","volume":"263","author":"Markaverich","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2006.05.017_bib9","doi-asserted-by":"crossref","first-page":"7203","DOI":"10.1016\/S0021-9258(18)68628-4","article-title":"Methyl p-hydroxyphenyllactate: an inhibitor of cell proliferation and an endogenous ligand for nuclear type ii binding sites","volume":"263","author":"Markaverich","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2006.05.017_bib10","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0022-4731(89)90234-3","article-title":"Estrogen regulation of methyl p-hydroxyphenyllactate hydrolysis: correlation with estrogen stimulation of rat uterine growth","volume":"33","author":"Markaverich","year":"1989","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.steroids.2006.05.017_bib11","first-page":"1470","article-title":"Methyl-p-hydroxyphenyllactate and nuclear type ii binding sites in malignant cells: metabolic fate and mammary tumor growth","volume":"50","author":"Markaverich","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib12","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0039-128X(96)00227-9","article-title":"Partial purification and characterization of methyl-p-hydroxyphenyllactate esterase in rat uterine cytosol","volume":"62","author":"Maybruk","year":"1997","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2006.05.017_bib13","first-page":"7","article-title":"Detection of esterase activity in nondenaturing nusieve agarose gels from the reliant gel system","volume":"11","author":"Maybruck","year":"1995","journal-title":"Resolut, FMC BioProd"},{"key":"10.1016\/j.steroids.2006.05.017_bib14","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1016\/S0021-9258(17)44279-7","article-title":"Preliminary characterization of an endogenous inhibitor of [3h]estradiol binding in rat uterine nuclei","volume":"258","author":"Markaverich","year":"1983","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2006.05.017_bib15","first-page":"1515","article-title":"An endogenous inhibitor of [3h]estradiol binding in normal and malignant tissues","volume":"44","author":"Markaverich","year":"1984","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib16","first-page":"1311","article-title":"Bioflavonoids, type ii [3h]estradiol binding sites and prostatic cancer cell proliferation","volume":"11","author":"Markaverich","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.steroids.2006.05.017_bib17","first-page":"1127","article-title":"Type ii [3h]estradiol binding site antagonists: inhibition of normal and malignant prostate cell growth and proliferation","volume":"12","author":"Markaverich","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.steroids.2006.05.017_bib18","first-page":"2482","article-title":"Nuclear type ii sites and malignant cell proliferation: inhibition by benzylidenecyclohexanones","volume":"52","author":"Markaverich","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1006\/bbrc.1997.7495","article-title":"Adlercreutz. 2,6-bis((3 4-dihydroxyphenyl)-methylene)cyclohexanone (bdhpc)-induced apoptosis and p53-independent growth inhibition: synergism with genestein","volume":"238","author":"Attalla","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib20","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0039-128X(93)90071-T","article-title":"Preliminary assessment of luteolin as an affinity ligand for type ii estrogen binding sites in rat uterine nuclear extracts","volume":"58","author":"Markaverich","year":"1993","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2006.05.017_bib21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0006-291X(02)02042-9","article-title":"Identification of rat uterine nuclear type ii [3h]estradiol binding sites as histone h4","volume":"296","author":"Shoulars","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-4731(88)90078-7","article-title":"Bioflavonoid interactions with rat uterine type ii binding sites and cell growth inhibition","volume":"29","author":"Markaverich","year":"1988","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.steroids.2006.05.017_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1042\/bj1280901","article-title":"Metabolism of apigenin and related compounds in the rat","volume":"128","author":"Griffiths","year":"1972","journal-title":"Biochem J"},{"key":"10.1016\/j.steroids.2006.05.017_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/endo-109-1-62","article-title":"Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type i and type ii sites by [3h]estradiol exchange","volume":"109","author":"Markaverich","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/1097-0215(20010720)95:4<205::AID-IJC1035>3.0.CO;2-Y","article-title":"Analysis of the potential contribution of estrogen receptor (er) b in er cytosolic assay of breast cancer","volume":"95","author":"Brouillet","year":"2001","journal-title":"Int J Cancer (Pred Oncol)"},{"key":"10.1016\/j.steroids.2006.05.017_bib26","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0006-291X(91)90680-6","article-title":"Preliminary characterization and partial purification of rat uterine nuclear type ii sites","volume":"177","author":"Markaverich","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0039-128X(01)00099-X","article-title":"Purification and characterization of nuclear type ii [3h]estradiol binding sites from the rat uterus: covalent labeling with [3h]luteolin","volume":"66","author":"Markaverich","year":"2001","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2006.05.017_bib28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0022-4731(87)90386-4","article-title":"Cytosol type ii sites in the rat uterus: interaction with an endogenous ligand","volume":"28","author":"Markaverich","year":"1987","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.steroids.2006.05.017_bib29","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1210\/en.143.3.941","article-title":"Antagonists selective for estrogen receptor","volume":"143","author":"Sun","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib30","doi-asserted-by":"crossref","first-page":"12705","DOI":"10.1016\/S0021-9258(18)37810-4","article-title":"Transcriptional regulation of c-myc oncogene expression by estrogen in hormone-responsive human breast cancer cells","volume":"263","author":"Dubik","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2006.05.017_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/0008-5472.CAN-03-2446","article-title":"Estrogen receptor b inhibits human breast cancer cell proliferation and tumor formation by causing g2 cell cycle arrest","volume":"64","author":"Paruthiyil","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib32","first-page":"1470","article-title":"Methyl p-hydroxyphenyllactate and nuclear type ii binding sites in malignant cells: metabolic fate and mammary tumor growth","volume":"50","author":"Markaverich","year":"1990","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib33","first-page":"1291","article-title":"Nuclear type ii [3h]estradiol binding sites in mcf-7 human breast cancer cells: binding interactions with 2,6-bis([3 4-dihydroxyphenyl]-methylene)-cyclohexanone esters and inhibition of cell proliferation","volume":"4","author":"Markaverich","year":"1994","journal-title":"Int J Oncol"},{"key":"10.1016\/j.steroids.2006.05.017_bib34","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1210\/endo-109-1-62","article-title":"Heterogeneity of nuclear estrogen-binding sites in the rat uterus: a simple method for the quantitation of type i and type ii sites by [3h]estradiol exchange","volume":"109","author":"Markaverich","year":"1981","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib35","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1095\/biolreprod.102.003392","article-title":"Treatment of rats with 17-\u0283 estradiol or relaxin rapidly inhibits uterine estrogen receptor \u0283l and \u02832 messenger ribonucleic acid levels","volume":"67","author":"Pillai","year":"2002","journal-title":"Biol Reprod"},{"key":"10.1016\/j.steroids.2006.05.017_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jhrc.1240110814","article-title":"Methyl p-hydroxyphenyllactate: identification in rat liver extracts","volume":"11","author":"Markaverich","year":"1988","journal-title":"J High Resolut Chromatogr Chromatogr Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib37","doi-asserted-by":"crossref","first-page":"4242","DOI":"10.1210\/en.139.10.4252","article-title":"Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor b","volume":"139","author":"Kuiper","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib38","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1006\/bbrc.2002.6499","article-title":"Identification of an endocrine disrupting agent from corn with mitogenic activity","volume":"291","author":"Markaverich","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.steroids.2006.05.017_bib39","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1210\/jc.82.7.2371","article-title":"Expression of estrogen receptor- beta in human breast tumors","volume":"82","author":"Dotzlaw","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2006.05.017_bib40","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1207\/S15327914NC4502_15","article-title":"Effects of the phytoestrogens genistein and daidzein on brca2 gene expression in breast cell lines","volume":"45","author":"Vissac-Sabatier","year":"2003","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.steroids.2006.05.017_bib41","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1136\/jcp.43.12.1004","article-title":"Type ii estrogen binding sites in human colorectal carcinoma","volume":"43","author":"Piantelli","year":"1990","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.steroids.2006.05.017_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/1097-0142(19930101)71:1<193::AID-CNCR2820710130>3.0.CO;2-C","article-title":"Type ii estrogen binding sites and antiproliferative activity of quercetin in human menigiomas","volume":"71","author":"Piantelli","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.steroids.2006.05.017_bib43","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/1523-1747.ep12317599","article-title":"Tamoxifen and quercetin interact with type ii estrogen binding sites and inhibit the growth of human melanoma cells","volume":"105","author":"Piantelli","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.steroids.2006.05.017_bib44","first-page":"528","article-title":"Selective increase in type ii estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats","volume":"53","author":"Ho","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.steroids.2006.05.017_bib45","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0960-0760(93)90103-4","article-title":"In vitro and in vivo inhibition of nuclear type ii estrogen binding sites in the dorsolateral prostate of noble rats","volume":"46","author":"Ho","year":"1993","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2006.05.017_bib46","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0960-0760(94)00170-Q","article-title":"Hormonal regulation of nuclear type ii estrogen binding sites in the dorsolateral prostate of noble rats","volume":"52","author":"Ho","year":"1995","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2006.05.017_bib47","first-page":"356","article-title":"Induction of aypical hyperplasia, apoptosis, and type ii estrogen-binding sites in the ventral prostates of noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta","volume":"73","author":"Ho","year":"1995","journal-title":"Lab Invest"},{"key":"10.1016\/j.steroids.2006.05.017_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2004.08.024","article-title":"Histone metabolic pathways and chromatin assembly factors as proliferation markers","volume":"220","author":"Polo","year":"2005","journal-title":"Cancer Lett"},{"key":"10.1016\/j.steroids.2006.05.017_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1095\/biolreprod24.1.171","article-title":"Differential stimulation of uterine cells by nafoxidine and clomiphene: relationship between nuclear estrogen receptors and type ii estrogen binding sites and cellular growth","volume":"24","author":"Markaverich","year":"1981","journal-title":"Biol Reprod"},{"key":"10.1016\/j.steroids.2006.05.017_bib50","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-4731(81)90164-3","article-title":"Progesterone and dexamethasone antagonism of uterine growth: role for a second nuclear estrogen binding site for estradiol in estrogen action","volume":"14","author":"Markaverich","year":"1981","journal-title":"J Steroid Biochem"},{"key":"10.1016\/j.steroids.2006.05.017_bib51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1677\/joe.0.1650359","article-title":"Localization of oestrogen receptor \u00e5 and oestrogen receptor J and androgen receptors in the rat reproductive organs","volume":"165","author":"Pelletier","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2006.05.017_bib52","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ejso.2004.06.019","article-title":"Estrogen receptor b and breast cancer","volume":"30","author":"Balfe","year":"2004","journal-title":"EJSO"},{"key":"10.1016\/j.steroids.2006.05.017_bib53","series-title":"Heterogeneity of estrogen binding sites on the nuclear matrix","author":"Clark","year":"1980"},{"key":"10.1016\/j.steroids.2006.05.017_bib54","doi-asserted-by":"crossref","unstructured":"Shoulars K, Rodriguez M, Crowley J, Turk J, Thompson T and Markaverich B. Regeration of type ii [3h]estradiol binding sites on recombinant histones h3 and h4. J Steroid Biochem Mol Biol 2005, submitted for publication.","DOI":"10.1016\/j.jsbmb.2005.11.009"},{"key":"10.1016\/j.steroids.2006.05.017_bib55","doi-asserted-by":"crossref","first-page":"9485","DOI":"10.1073\/pnas.96.17.9485","article-title":"Steroid receptor coactivator (src-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin","volume":"96","author":"Liu","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.steroids.2006.05.017_bib56","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1063127","article-title":"Translating the histone code","volume":"293","author":"JenuweinTaA","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.steroids.2006.05.017_bib57","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1101\/gad.906601","article-title":"Binding of c-myc to chromatin mediates mitogen-induced acetylation of histone h4 and gene activation","volume":"85","author":"Frank","year":"2001","journal-title":"Genes Dev"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X06001334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X06001334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T21:42:08Z","timestamp":1683495728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X06001334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0039128X06001334"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2006.05.017","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}